Evidence map›Paper›PMID 31733097›Full record

ArticleAddiction biology2020

The loss of NMDAR-dependent LTD following cannabinoid self-administration is restored by positive allosteric modulation of CB1 receptors.

Daniela Neuhofer, Sade M Spencer, Vivian C Chioma, Lauren N Beloate, Danielle Schwartz, Peter W Kalivas

Open access · greenAbstract read
In one paragraph

Article in Addiction biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. The neuroimmune-glutamate hypothesis of addiction.Neuroscience and biobehavioral reviews · 2026
    Review
  2. Article
  3. Review
  4. Experimenter administered ΔPharmacology, biochemistry, and behavior · 2023
    Article
  5. ΔAddiction biology · 2023
    Article
  6. Review
  7. Review
  8. Cannabinoid use is enhanced by stress and changes conditioned stress responses.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2022
    Article
  9. Impairment of Synaptic Plasticity by Cannabis, ΔCold Spring Harbor perspectives in medicine · 2021
    Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Daniela NeuhoferDepartment of Neurosciences, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0001-5726-7855
Sade M SpencerDepartment of Neurosciences, Medical University of South Carolina, Charleston, South Carolina.
Vivian C ChiomaDepartment of Neurosciences, Medical University of South Carolina, Charleston, South Carolina.
Lauren N BeloateDepartment of Neurosciences, Medical University of South Carolina, Charleston, South Carolina.
Danielle SchwartzDepartment of Neurosciences, Medical University of South Carolina, Charleston, South Carolina.
Peter W KalivasDepartment of Neurosciences, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0001-9487-0119
Medical University of South Carolina · USUniversity of Minnesota · US

Funding

Selective Restoration of KCNQ Channel Inhibition in the PFC to Inhibit Cue-InducP50DA015369 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RIEGEL, ARTHUR C · 2003 to 2017
$18.6M
Vocational Training for Drug Dependent WomenP50DA016511 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2002 to 2017
$14.5M
COCA: Project 4. Neurocircuit Strategy to Decrease Cocaine Cue ReactivityP50DA046373 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HANLON, COLLEEN A · 2019 to 2023
$9.9M
GLUTAMATE AND CRAVING FOR COCAINER01DA012513 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KALIVAS, PETER W · 2000 to 2024
$7.5M
MUSC Minority Student Development ProgramR25GM072643 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ERGUL, ADVIYE, RINKER, JENNIFER ANNE · 2005 to 2023
$5.8M
OPIOIDS, AMPHETAMINE &COCAIN IN DRUG ABUSER01DA003906 · NIDA · WASHINGTON STATE UNIVERSITY · PI KALIVAS, PETER W · 1985 to 2019
$3.6M
COCAINE, OPIOIDS AND DRUG ABUSER37DA003906 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KALIVAS, PETER W · 2000 to 2009
$3.0M
MUSC Post-Baccalaureate Research Education ProgramR25GM113278 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DELEON-PENNELL, KRISTINE Y, PENROD-MARTIN, RACHEL · 2015 to 2024
$2.7M
Neuroadaptation produced by acute PTSD-like stress create vulnerability for cannabis addictionI01BX004727 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI James M Otis · 2019 to 2026
–
BLRD VA I01 BX004727NIDA NIH HHS P50 DA015369NIDA NIH HHS P50 DA016511NIDA NIH HHS P50 DA046373NIDA NIH HHS R01 DA003906NIDA NIH HHS R01 DA012513NIDA NIH HHS R37 DA003906NIGMS NIH HHS R25 GM072643NIGMS NIH HHS R25 GM113278NIH HHS DA015369NIH HHS GM072643
6 · The paper itself

Abstract

Glutamatergic plasticity in the nucleus accumbens core (NAcore) is a key neuronal process in appetitive learning and contributes to pathologies such as drug addiction. Understanding how this plasticity factors into cannabis addiction and relapse has been hampered by the lack of a rodent model of cannabis self-administration. We used intravenous self-administration of two constituents of cannabis, Δ

Indexed as

Allosteric RegulationAnimalsBehavior, AddictiveCannabidiolCannabinoid Receptor AgonistsCannabinoidsDronabinolGlutamic AcidIndolesLong-Term Synaptic DepressionMaleNucleus AccumbensRatsRats, Sprague-DawleyReceptor, Cannabinoid, CB1Receptors, N-Methyl-D-Aspartate3-(2-nitro-1-phenylethyl)-2-phenyl-1H-indoleCannabidiolCannabinoid Receptor AgonistsCannabinoidsDronabinolGlutamic AcidIndolesReceptor, Cannabinoid, CB1Receptors, N-Methyl-D-Aspartateaddictioncannabinoidssynaptic plasticity

Identifiers

PMID31733097
PMCPMC7962172
OpenAlexW2985983331

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.